Marko Radulović - Search Results

Year	Number of Results
2003	1
2004	1
2006	3
2007	2
2009	2
2010	1
2011	1
2012	1
2014	2
2015	4
2016	4
2017	5
2018	5
2019	3
2020	1
2021	3
2022	2

1

Computational analysis of MRIs predicts osteosarcoma chemoresponsiveness.

Djuričić GJ, Rajković N, Milošević N, Sopta JP, Borić I, Dučić S, Apostolović M, Radulovic M. Djuričić GJ, et al. Among authors: radulovic m. Biomark Med. 2021 Aug;15(12):929-940. doi: 10.2217/bmm-2020-0876. Epub 2021 Jul 8. Biomark Med. 2021. PMID: 34236239

2

Proteomic approaches to understanding the role of the cytoskeleton in host-defense mechanisms.

Radulovic M, Godovac-Zimmermann J. Radulovic M, et al. Expert Rev Proteomics. 2011 Feb;8(1):117-26. doi: 10.1586/epr.10.91. Expert Rev Proteomics. 2011. PMID: 21329431 Free PMC article. Review.

3

Spatial perspectives in the redox code-Mass spectrometric proteomics studies of moonlighting proteins.

Pinto G, Radulovic M, Godovac-Zimmermann J. Pinto G, et al. Among authors: radulovic m. Mass Spectrom Rev. 2018 Jan;37(1):81-100. doi: 10.1002/mas.21508. Epub 2016 May 17. Mass Spectrom Rev. 2018. PMID: 27186965 Review.

4

The prognostic value of cyclin D1 in breast cancer patients treated with hormonal therapy: A pilot study.

Todorović-Raković N, Milovanović J, Durosaro SO, Radulovic M. Todorović-Raković N, et al. Among authors: radulovic m. Pathol Res Pract. 2021 Jun;222:153430. doi: 10.1016/j.prp.2021.153430. Epub 2021 Apr 5. Pathol Res Pract. 2021. PMID: 33839437

5

The significance of HOXB7 and IL17RB serum levels in prognosis of hormonally dependent breast cancer: A pilot study.

Todorović-Raković N, Milovanović J, Greenman J, Radulovic M. Todorović-Raković N, et al. Among authors: radulovic m. Adv Med Sci. 2021 Sep;66(2):359-365. doi: 10.1016/j.advms.2021.07.007. Epub 2021 Jul 22. Adv Med Sci. 2021. PMID: 34304115

6

Dynamics of Forest Fragmentation and Connectivity Using Particle and Fractal Analysis.

Andronache I, Marin M, Fischer R, Ahammer H, Radulovic M, Ciobotaru AM, Jelinek HF, Di Ieva A, Pintilii RD, Drăghici CC, Herman GV, Nicula AS, Simion AG, Loghin IV, Diaconu DC, Peptenatu D. Andronache I, et al. Among authors: radulovic m. Sci Rep. 2019 Aug 22;9(1):12228. doi: 10.1038/s41598-019-48277-z. Sci Rep. 2019. PMID: 31439903 Free PMC article.

7

Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer.

Milovanović J, Todorović-Raković N, Radulovic M. Milovanović J, et al. Among authors: radulovic m. Cytokine. 2019 Jun;118:93-98. doi: 10.1016/j.cyto.2018.02.019. Epub 2018 Feb 24. Cytokine. 2019. PMID: 29482885

8

Analysis of Spatial Distribution and Prognostic Value of Different Pan Cytokeratin Immunostaining Intensities in Breast Tumor Tissue Sections.

Vranes V, Vujasinović T, Rajković N, Kanjer K, Milošević NT, Radulovic M. Vranes V, et al. Among authors: radulovic m. Int J Mol Sci. 2020 Jun 22;21(12):4434. doi: 10.3390/ijms21124434. Int J Mol Sci. 2020. PMID: 32580421 Free PMC article.

9

Subproteome analysis of the neutrophil cytoskeleton.

Xu P, Crawford M, Way M, Godovac-Zimmermann J, Segal AW, Radulovic M. Xu P, et al. Among authors: radulovic m. Proteomics. 2009 Apr;9(7):2037-49. doi: 10.1002/pmic.200800674. Proteomics. 2009. PMID: 19294702 Free PMC article.

10

Prognostic biomarker value of binary and grayscale breast tumor histopathology images.

Rajković N, Vujasinović T, Kanjer K, Milošević NT, Nikolić-Vukosavljević D, Radulovic M. Rajković N, et al. Among authors: radulovic m. Biomark Med. 2016 Oct;10(10):1049-1059. doi: 10.2217/bmm-2016-0165. Epub 2016 Sep 29. Biomark Med. 2016. PMID: 27680104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results